MEDS chooses Obeya

We are finally able to announce that Obeya has begun a strategic and operational partnership with the online pharmacy MEDS to support their PR efforts.

– MEDS is a fast-growing sensation that we believe will continue to amaze. We look forward to contributing to MEDS' continued success, says Maria Hazard, CEO of Obeya.

In 2020, MEDS, an online pharmacy founded by Björn Thorngren, had a turnover of 229 million SEK. The company also carried out a new share issue in early 2021, which raised 167 million SEK in new capital.

– We are convinced that Obeya will be an important partner in our future initiatives. Obeya’s combination of proactivity and creativity is something we believe will be very valuable, says Carl Jansson, CMO at MEDS.